Trial · NCT02248220
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in cumulative daily doses of Sifrol® | up to 8 weeks | Changes in the doses between visits are evaluated using Wilcoxon's signed rank test |
| Primary | Changes in cumulative daily doses of L-dopa | up to 8 weeks | Changes in the doses between visits are evaluated using Wilcoxon's signed rank test |
| Secondary | Change from Baseline in Short Parkinson Evaluation Scale (SPES) total score | Baseline, after 8 weeks | |
| Secondary | Change from Baseline in SPES subscales | Baseline, after 8 weeks | Psychopathological disturbances, Activities of daily living, Evaluation of motor function, Tremor, Resting Tremor, Postural tremor, Complications of therapy |
| Secondary | Change from Baseline in Snaith-Hamilton-Pleasure-Scale total score | Baseline, after 8 weeks | patients with SPES depression \>= 2 |
| Secondary | Change from Baseline in Tremor Impact Scale (TIS-D) total score | Baseline, after 8 weeks | |
| Secondary | Change from Baseline in global Parkinson's Disease (PD) symptoms | Baseline, after 8 weeks | Akinesia, anhedonia, depression, dyskinesia, motor fluctuation, cognitive disturbances, rigor and tremor |
| Secondary | Global assessment of efficacy by investigator on a 5-point scale | after 8 weeks | |
| Secondary | Global assessment of tolerability by investigator on a 5-point scale | after 8 weeks | |
| Secondary | Number of patients with adverse events | up to 8 weeks | |
| Secondary | Number of patients with adverse drug reactions | up to 8 weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02248220/registered